Biological Biomarkers of Response and Resistance to Immune Checkpoint Inhibitors in Renal Cell Carcinoma

por Masson, Claire, Thouvenin, Jonathan, Boudier, Philippe, Maillet, Denis, Kuchler-Bopp, Sabine, Barthélémy, Philippe, Massfelder, Thierry
Publicado 2023

Sarcomatoid Dedifferentiation in Renal Cell Carcinoma: From Novel Molecular Insights to New Clinical Opportunities

por Debien, Véronique, Thouvenin, Jonathan, Lindner, Véronique, Barthélémy, Philippe, Lang, Hervé, Flippot, Ronan, Malouf, Gabriel G.
Publicado 2019

Complete Response in Metastatic Clear Cell Renal Cell Carcinoma Patients Treated with Immune-Checkpoint Inhibitors: Remission or Healing? How to Improve Patients’ Outcomes?

por Thouvenin, Jonathan, Masson, Claire, Boudier, Philippe, Maillet, Denis, Kuchler-Bopp, Sabine, Barthélémy, Philippe, Massfelder, Thierry
Publicado 2023

Efficacy of Immune Checkpoint Inhibitors in Upper Tract Urothelial Carcinomas: Current Knowledge and Future Directions

por Thouvenin, Jonathan, Martínez Chanzá, Nieves, Alhalabi, Omar, Lang, Hervé, Tannir, Nizar M., Barthélémy, Philippe, Malouf, Gabriel G.
Publicado 2021

Metastatic Renal Medullary and Collecting Duct Carcinoma in the Era of Antiangiogenic and Immune Checkpoint Inhibitors: A Multicentric Retrospective Study

por Guillaume, Zoé, Colomba, Emeline, Thouvenin, Jonathan, Saldana, Carolina, Campedel, Luca, Dumont, Clément, Laguerre, Brigitte, Maillet, Denis, Vicier, Cécile, Rolland, Frédéric, Borchiellini, Delphine, Barthelemy, Philippe, Albiges, Laurence, Auclin, Edouard, Roulleaux Dugage, Matthieu, Oudard, Stéphane, Thibault, Constance
Publicado 2022

Immune Checkpoint Therapy Combinations in Adult Advanced MiT Family Translocation Renal Cell Carcinomas

por Alhalabi, Omar, Thouvenin, Jonathan, Négrier, Sylvie, Vano, Yann-Alexandre, Campedel, Luca, Hasanov, Elshad, Bakouny, Ziad, Hahn, Andrew W, Bilen, Mehmet Asim, Msaouel, Pavlos, Choueiri, Toni K, Viswanathan, Srinivas R, Sircar, Kanishka, Albiges, Laurence, Malouf, Gabriel G, Tannir, Nizar M
Publicado 2023

SMARCB1 regulates a TFCP2L1-MYC transcriptional switch promoting renal medullary carcinoma transformation and ferroptosis resistance

por Vokshi, Bujamin H., Davidson, Guillaume, Tawanaie Pour Sedehi, Nassim, Helleux, Alexandra, Rippinger, Marc, Haller, Alexandre R., Gantzer, Justine, Thouvenin, Jonathan, Baltzinger, Philippe, Bouarich, Rachida, Manriquez, Valeria, Zaidi, Sakina, Rao, Priya, Msaouel, Pavlos, Su, Xiaoping, Lang, Hervé, Tricard, Thibault, Lindner, Véronique, Surdez, Didier, Kurtz, Jean-Emmanuel, Bourdeaut, Franck, Tannir, Nizar M., Davidson, Irwin, Malouf, Gabriel G.
Publicado 2023

Efficacy of Cabozantinib in Metastatic MiT Family Translocation Renal Cell Carcinomas

por Thouvenin, Jonathan, Alhalabi, Omar, Carlo, Maria, Carril-Ajuria, Lucia, Hirsch, Laure, Martinez-Chanza, Nieves, Négrier, Sylvie, Campedel, Luca, Martini, Dylan, Borchiellini, Delphine, Chahoud, Jad, Lodi, Massimo, Barthélémy, Philippe, Hasanov, Elshad, Hahn, Andrew W, Gil, Thierry, Viswanathan, Srinivas R, Bakouny, Ziad, Msaouel, Pavlos, Asim Bilen, Mehmet, Choueiri, Toni K, Albiges, Laurence, Tannir, Nizar M, Malouf, Gabriel G
Publicado 2022